Akebia Therapeutics, Inc.
SEC Filing List
AKBA CIK: 0001517022
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 05/12/2026 | ||||
| 8-K | Current report filing | Akebia Therapeutics, Inc. | 05/07/2026 | ||
| 10-Q | Quarterly report pursuant to Section 13 ... | Akebia Therapeutics, Inc. | 05/07/2026 | ||
| ARS | Annual report to security holders | Akebia Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/29/2026 | |
| DEF 14A | Definitive proxy statements | Akebia Therapeutics, Inc. | 04/28/2026 | ||
| DEFA14A | Definitive additional proxy soliciting m... | Akebia Therapeutics, Inc. | 04/28/2026 | ||
| PRE 14A | Preliminary proxy statement not related ... | Akebia Therapeutics, Inc. | 04/15/2026 | ||
| 3 | Initial statement of beneficial ownershi... | Vickers Philip J. | Vickers Philip J. /fa | 04/03/2026 | |
| 4 | Statement of changes in beneficial owner... | Vickers Philip J. | Vickers Philip J. /fa | 04/03/2026 | |
| 8-K | Current report filing | Akebia Therapeutics, Inc. | 04/01/2026 | ||
| No record found. | |||||
| Load More | |||||
